Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis

Heidi Harjunpää, Stephen J. Blake, Elizabeth Ahern, Stacey Allen, Jing Liu, Juming Yan, Viviana Lutzky, Kazuyoshi Takeda, Amy Roman Aguilera, Camille Guillerey, Deepak Mittal, Xian Yang Li, William C. Dougall, Mark J. Smyth, Michele W. L. Teng

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number1445949
JournalOncoImmunology
Volume7
Issue number7
Number of pages11
ISSN2162-402X
DOIs
Publication statusPublished - 2018
Externally publishedYes
MoE publication typeA1 Journal article-refereed

Fields of Science

  • PD-1
  • CD96
  • TIGIT
  • immune homeostasis
  • tumor immunity
  • REGULATORY T-CELLS
  • CANCER-IMMUNOTHERAPY
  • BRAF INHIBITORS
  • CUTTING EDGE
  • MICE
  • CHECKPOINT
  • IDENTIFICATION
  • RESPONSES
  • MOLECULE
  • MELANOMA

Cite this